Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Home
Communities
Explore
More
Language
English
English
Biocon (India)
h-index: 54
Total citations: 14,669
Total papers: 939
Homepage:
http://www.biocon.com/
Recent papers from Biocon (India)
Celery seed extract attenuates sarcopenic obesity and age-related sarcopenia by reducing intramuscular lipid accumulation in mice
Frontiers in Nutrition · 2026
Deciphering Protein–Protein Interactions in Suspension Formulation of Neutral Protamine Hagedorn Insulin Using Hydrogen/Deuterium Exchange-Mass Spectrometry
Analytical Chemistry · 2026
Gut microbiome and immunotherapy in advanced non–small cell lung cancer: a prospective cohort study
BMC Cancer · 2026
Clinical Profile of patients attending Well Women Clinic in an Underprivileged Area in Bengaluru City
Journal of Mid-life Health · 2026
Risk Factors and Prevalence of Antenatal Psychiatric Symptoms: A Cross-Sectional Study in an Underprivileged Urban Setting
Healthline · 2026
Ecological and engineered modulation of the mosquito microbiome: mechanisms, vector competence, and translational prospects for disease control
Frontiers in Microbiology · 2026
Humanized Antibodies Targeting Ectodomains of IL ‐ 6R and GP130 Suppress IL ‐6/ STAT3 Signalling and Tumour Growth in Breast Cancer Models
Journal of Cellular and Molecular Medicine · 2026
Drug Delivery Strategy Exploiting Amino Acid Prodrugs: Improving Oral Bioavailability and Overcoming Nonlinear Pharmacokinetic Challenges Following Dose Escalation of a CK2 Inhibitor with Poor Solubility
Journal of Medicinal Chemistry · 2026
A randomized, double-blind, two-arm, single-dose, parallel study to compare the pharmacokinetics, pharmacodynamics, safety, and immunogenicity of Bmab 1000 and originator denosumab in healthy male participants.
Journal of Clinical Oncology · 2026
Engineering host‑defense peptides enhanced by artificial intelligence and nano delivery systems to overcome biofilms and antimicrobial resistance
Engineering Microbiology · 2026
Comparability of aflibercept biosimilar with reference aflibercept in diabetic macular edema: subgroup analysis of the pivotal Phase-III insight randomized clinical trial
Expert Opinion on Biological Therapy · 2026
Differential immunogenicity of biosimilar monoclonal antibodies: overrated and overemphasized?
Drug Discovery Today · 2026
Observational study of trastuzumab biosimilar in patients with HER2-positive breast cancer under routine clinical practice conditions in Morocco
BMC Cancer · 2026
Dietary diversity and nutritional status of children enrolled in Anganwadis of Anekal Taluk, Bengaluru Urban District
Journal of Family Medicine and Primary Care · 2026
Green synthesis of AgNPs from Ajwain leaves: Exploring its therapeutic potential for antibacterial, anti-inflammatory, anti-cancerous and antioxidant effects
Inorganic Chemistry Communications · 2026
Efficacy, pharmacodynamics, pharmacokinetics, safety, and immunogenicity of Bmab 1000 versus reference denosumab: 78-wk results from a randomized, double-blind, multicenter, parallel-arm phase 3 trial (DEVOTE) in women with postmenopausal osteoporosis
JBMR Plus · 2026
Spatial Control in Covalent Multi-Enzyme Complexes Enables Efficient and Selective Redox Biocatalysis
Journal of Agricultural and Food Chemistry · 2026
Metabolomic Insights into Head and Neck Cancer: Recent Advances and Future Directions
Current Oncology · 2026
Safety and efficacy of biosimilar aflibercept MYL-1701P in diabetic macular oedema: 20-week extension results following the INSIGHT pivotal trial
BMJ Open Ophthalmology · 2026
Driving In Vivo Multienzyme Cascades Forward: Regulatory Strategies for Enhanced Biocatalysis
ACS Synthetic Biology · 2026